Factors determining homocysteine levels in Russian patients with stable coronary heart disease

Aim. To identify the factors determining homocysteine (HMC) levels in Russian patients with stable coronary heart disease (CHD). Material and methods. The study included 506 patients (388 men; mean age 59,4±12,2 years) with stable CHD. Classical risk factors (RFs) of cardiovascular disease (CVD), re...

Full description

Saved in:
Bibliographic Details
Main Authors: O. O. Shakhmatova, A. L. Komarov, D. V. Rebrikov, M. A. Turchaninova, T. I. Kotkina, A. V. Bolvacheva, A. D. Deev, A. B. Dobrovolsky, E. V. Titaeva, E. A. Panchenko
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2010-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2105
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689298446581760
author O. O. Shakhmatova
A. L. Komarov
D. V. Rebrikov
M. A. Turchaninova
T. I. Kotkina
A. V. Bolvacheva
A. D. Deev
A. B. Dobrovolsky
E. V. Titaeva
E. A. Panchenko
author_facet O. O. Shakhmatova
A. L. Komarov
D. V. Rebrikov
M. A. Turchaninova
T. I. Kotkina
A. V. Bolvacheva
A. D. Deev
A. B. Dobrovolsky
E. V. Titaeva
E. A. Panchenko
author_sort O. O. Shakhmatova
collection DOAJ
description Aim. To identify the factors determining homocysteine (HMC) levels in Russian patients with stable coronary heart disease (CHD). Material and methods. The study included 506 patients (388 men; mean age 59,4±12,2 years) with stable CHD. Classical risk factors (RFs) of cardiovascular disease (CVD), renal function (creatinine clearance by Cockroft-Gault formula), and atherosclerotic pathology of other localizations were assessed. The levels of plasma HMC, folate, and cobalamin were measured. Genetic analysis was performed using the real-time polymerase chain reaction method. Results. In 432 patients (85,4 %), hyperhomocysteinemia was diagnosed. The mean HMC level was 14,3±4,6 mkmol/l. According to multifactor analysis results, HMC level was independently associated with folate level (beta coefficient -3,86, p<0,0001), cobalamin level (beta -5,73, p<0,0001), and MTRR 66AA genotype (beta 10,71, p<0,0005). In addition, HMC concentration was linked to the following combinations: MTRR 66G allele + folate level (beta 1,12, p<0,0001), MTRR 66AA allele + cobalamin level (beta 0,012, p<0,0001), TCN 776G allele + cobalamin level (beta -0,03, p<0,0001), TCN 776G allele + folate level (beta 0,58, p<0,0009), MTR 2756G allele + cobalamin level (beta 0,004, p<0,002), MTRR 66G allele + creatinine clearance <90 ml/min (beta 0,08, p<0,001), and TCN 776G allele + creatinine clearance <90 ml/min (beta 0,07, p<0,0007). Conclusion. In Russian patients with stable CHD, HMC level was associated with folate and cobalamin concentrations and MTRR 66AA genotype, as well as with MTR 2756G, MTRR 66G, and TCN 776G alleles combined with vitamin concentrations and renal function.
format Article
id doaj-art-3fd941d2f5c246d29eaf20407799db75
institution DOAJ
issn 1728-8800
2619-0125
language Russian
publishDate 2010-08-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-3fd941d2f5c246d29eaf20407799db752025-08-20T03:21:40Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252010-08-019449581814Factors determining homocysteine levels in Russian patients with stable coronary heart diseaseO. O. Shakhmatova0A. L. Komarov1D. V. Rebrikov2M. A. Turchaninova3T. I. Kotkina4A. V. Bolvacheva5A. D. Deev6A. B. Dobrovolsky7E. V. Titaeva8E. A. Panchenko9Russian Cardiology Scientific and Clinical ComplexRussian Cardiology Scientific and Clinical ComplexDNA-Technology Company; N.I. Vavilov Institute of General Genetics; Russian Academy of SciencesDNA-Technology CompanyRussian Cardiology Scientific and Clinical ComplexRussian Cardiology Scientific and Clinical ComplexState Research Centre f or Preventive Medicine. MoscowRussian Cardiology Scientific and Clinical ComplexRussian Cardiology Scientific and Clinical ComplexRussian Cardiology Scientific and Clinical ComplexAim. To identify the factors determining homocysteine (HMC) levels in Russian patients with stable coronary heart disease (CHD). Material and methods. The study included 506 patients (388 men; mean age 59,4±12,2 years) with stable CHD. Classical risk factors (RFs) of cardiovascular disease (CVD), renal function (creatinine clearance by Cockroft-Gault formula), and atherosclerotic pathology of other localizations were assessed. The levels of plasma HMC, folate, and cobalamin were measured. Genetic analysis was performed using the real-time polymerase chain reaction method. Results. In 432 patients (85,4 %), hyperhomocysteinemia was diagnosed. The mean HMC level was 14,3±4,6 mkmol/l. According to multifactor analysis results, HMC level was independently associated with folate level (beta coefficient -3,86, p<0,0001), cobalamin level (beta -5,73, p<0,0001), and MTRR 66AA genotype (beta 10,71, p<0,0005). In addition, HMC concentration was linked to the following combinations: MTRR 66G allele + folate level (beta 1,12, p<0,0001), MTRR 66AA allele + cobalamin level (beta 0,012, p<0,0001), TCN 776G allele + cobalamin level (beta -0,03, p<0,0001), TCN 776G allele + folate level (beta 0,58, p<0,0009), MTR 2756G allele + cobalamin level (beta 0,004, p<0,002), MTRR 66G allele + creatinine clearance <90 ml/min (beta 0,08, p<0,001), and TCN 776G allele + creatinine clearance <90 ml/min (beta 0,07, p<0,0007). Conclusion. In Russian patients with stable CHD, HMC level was associated with folate and cobalamin concentrations and MTRR 66AA genotype, as well as with MTR 2756G, MTRR 66G, and TCN 776G alleles combined with vitamin concentrations and renal function.https://cardiovascular.elpub.ru/jour/article/view/2105homocysteineatherothrombosisfolatecobalamingenetic polymorphism
spellingShingle O. O. Shakhmatova
A. L. Komarov
D. V. Rebrikov
M. A. Turchaninova
T. I. Kotkina
A. V. Bolvacheva
A. D. Deev
A. B. Dobrovolsky
E. V. Titaeva
E. A. Panchenko
Factors determining homocysteine levels in Russian patients with stable coronary heart disease
Кардиоваскулярная терапия и профилактика
homocysteine
atherothrombosis
folate
cobalamin
genetic polymorphism
title Factors determining homocysteine levels in Russian patients with stable coronary heart disease
title_full Factors determining homocysteine levels in Russian patients with stable coronary heart disease
title_fullStr Factors determining homocysteine levels in Russian patients with stable coronary heart disease
title_full_unstemmed Factors determining homocysteine levels in Russian patients with stable coronary heart disease
title_short Factors determining homocysteine levels in Russian patients with stable coronary heart disease
title_sort factors determining homocysteine levels in russian patients with stable coronary heart disease
topic homocysteine
atherothrombosis
folate
cobalamin
genetic polymorphism
url https://cardiovascular.elpub.ru/jour/article/view/2105
work_keys_str_mv AT ooshakhmatova factorsdetermininghomocysteinelevelsinrussianpatientswithstablecoronaryheartdisease
AT alkomarov factorsdetermininghomocysteinelevelsinrussianpatientswithstablecoronaryheartdisease
AT dvrebrikov factorsdetermininghomocysteinelevelsinrussianpatientswithstablecoronaryheartdisease
AT maturchaninova factorsdetermininghomocysteinelevelsinrussianpatientswithstablecoronaryheartdisease
AT tikotkina factorsdetermininghomocysteinelevelsinrussianpatientswithstablecoronaryheartdisease
AT avbolvacheva factorsdetermininghomocysteinelevelsinrussianpatientswithstablecoronaryheartdisease
AT addeev factorsdetermininghomocysteinelevelsinrussianpatientswithstablecoronaryheartdisease
AT abdobrovolsky factorsdetermininghomocysteinelevelsinrussianpatientswithstablecoronaryheartdisease
AT evtitaeva factorsdetermininghomocysteinelevelsinrussianpatientswithstablecoronaryheartdisease
AT eapanchenko factorsdetermininghomocysteinelevelsinrussianpatientswithstablecoronaryheartdisease